# US 2012/0252052 A1 · Method for multiple quantification of amino group-containing non-peptidic compound with high efficiency and high sensitivity and kit therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252052 A1
- Document ID: US20120252052A1
- Status: Published application
- Kind: A1
- Application number: 13/436,393
- Filed: 2012-03-30
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: Taiyo Nippon Sanso Corporation; National University Corporation University of Fukui
- Inventors: Shigeru MATSUKAWA; Kazumi NARITA; Haruki SHIMODAIRA
- Web page: https://patentgrep.com/patent/US20120252052A1

## CPC

- C07C 211/48: N-alkylated amines
- C07D 213/04: having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D 213/20: Quaternary compounds thereof
- G01N 33/6806: {Determination of free amino acids}
- G01N 33/9413: {Dopamine}
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

A method of quantifying a target non-peptidic compound having an amino group contained in one or more biological samples, which comprises a step of producing a difference in the mass of the target non-peptidic compound between samples, by using a combination of two or more kinds of stable isotopes of a compound represented by the formula (I): wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound; and a kit and the like usable for such method.

## Claims

### Claim 1

A method of quantifying a target non-peptidic compound having an amino group contained in one or more biological samples, which comprises the following steps:
(step 1) a step of preparing one or more biological samples to be analyzed, and an internal standard sample containing a known quantity of the target non-peptidic compound;
(step 2) a step of adding, as a compound indicative of mixing ratio, an amino group-containing non-peptidic compound, which is absent in the one or more biological samples and the internal standard sample, to each of the one or more biological samples and the internal standard sample, to a known concentration;
(step 3) a step of producing a difference in the mass of the target non-peptidic compound between samples comprising the one or more biological samples and the internal standard sample, and in the mass of the compound indicative of mixing ratio between samples comprising the one or more biological samples and the internal standard sample, by using a combination of two or more kinds of stable isotopes of a compound represented by the formula (I):
wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound;
(step 4) a step of taking a given amount each from the one or more biological samples and the internal standard sample, and mixing them to give a mixture;
(step 5) a step of subjecting the mixture to mass spectrometry, and obtaining the intensities of peaks in a mass spectrum, which correspond to the masses of the target non-peptidic compounds having a mass difference from each other, and the intensities of peaks in the mass spectrum, which correspond to the masses of the compounds indicative of mixing ratio having a mass difference from each other;
(step 6) a step of determining a quantitative ratio between the target non-peptidic compounds having a mass difference from each other, which are contained in the mixture, based on an intensity ratio of the intensity corresponding to each of the target non-peptidic compounds derived from each of the one or more biological samples, and the intensity corresponding to the target non-peptidic compound derived from the internal standard sample; and
(step 7) a step of determining an absolute quantity of the target non-peptidic compound contained in each of the one or more biological samples, based on the quantitative ratio determined in step 6 and a mixing ratio of the samples determined by comparison of the intensities of peaks in the mass spectrum, which correspond to the masses of the compounds indicative of mixing ratio having a mass difference from each other.

### Claim 2 (depends on 1)

The method of claim 1, wherein the compound of the formula (I) is 2,4,6-trimethylpyrylium.

### Claim 3 (depends on 1)

The method of claim 1, wherein at least one of the target non-peptidic compounds and the compounds indicative of mixing ratio, from which the peak intensity obtained in step 5 is derived, is a compound represented by the formula (II):
wherein R1 and R2 are as defined above, and R is any optionally substituted hydrocarbon group, excluding a compound having a peptide bond, or a salt thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the combination comprises 5 or more kinds of stable isotopes.

### Claim 5 (depends on 1)

The method of claim 1, wherein the target non-peptidic compound is biologically active amine and/or amino acid.

### Claim 6 (depends on 5)

The method of claim 5, wherein the biologically active amine is dopamine.

### Claim 7 (depends on 1)

The method of claim 1, wherein the mass spectrometry is performed by a nano-liquid chromatographic mass spectrometer.

### Claim 8

A kit for quantifying a target non-peptidic compound having an amino group contained in one or more biological samples, which comprises a combination of two or more kinds of stable isotopes of a compound represented by the formula (I):
wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound.

### Claim 9 (depends on 8)

The kit of claim 8, wherein the compound of the formula (I) is 2,4,6-trimethylpyrylium.

### Claim 10 (depends on 9)

The kit of claim 9, wherein the combination of two or more kinds of stable isotopes comprises two or more kinds of compounds selected from the group consisting of Py0, Py1, Py2, Py3, Py4, Py5, Py6, Py7 and Py8 represented by the formula (III):
wherein carbon atoms shown by black balls have a mass number of 13, and salts thereof.

### Claim 11

A compound represented by the formula (II):
wherein R1 and R2 are the same or different and each is hydrogen, halogen or alkyl, and R is any optionally substituted hydrocarbon group,
which contains at least one carbon atom having a mass number of 13 at a position other than R in the formula (II),
excluding a compound having a peptide bond, or a salt thereof.

### Claim 12

A compound represented by the formula (IV):
wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, and R is any optionally substituted hydrocarbon group,
which contains at least one carbon atom having a mass number of 13 at a position other than R in the formula (IV),
excluding a compound having a peptide bond, or a salt thereof.
